LMO2 and neoplasm: The upregulated Rosa26‐Lmo2 + Sca1‐Cre signature shows a significant enrichment in the human T‐ALL group which is in accordance with the human T‐ALL situation wherein the expression of LMO2 is present throughout in tumor cells.